MeVis Medical Solutions AG (FRA:M3V)

Market Cap	45.86M
Revenue (ttm)	16.64M
Net Income (ttm)	4.30M
Shares Out	n/a
EPS (ttm)	2.36
PE Ratio	10.66
Forward PE	n/a
Dividend	0.95 (3.77%)
Ex-Dividend Date	Mar 26, 2025

Volume	20
Average Volume	139
Open	25.20
Previous Close	25.20
Day's Range	25.20 - 25.20
52-Week Range	22.80 - 26.80
Beta	n/a
RSI	33.44
Earnings Date	May 27, 2025

About FRA:M3V

MeVis Medical Solutions AG develops, markets, and sells software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company's clinical focuses are image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resona...

• Industry: Prepackaged Software
• Founded: 1997
• Employees: 100
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: M3V

Financial Performance

In 2024, FRA:M3V's revenue was 16.97 million, a decrease of -2.14% compared to the previous year's 17.34 million. Earnings were 4.56 million, a decrease of -7.29%.